Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

NCT04166565 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma
Extramedullary Plasmacytoma

Interventions

DRUG: Daratumumab
DRUG: Bortezomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

Stichting European Myeloma Network

Collaborators

[object Object]